Three Massachusetts Hospitals Using Protein Forest's Proteomics Software

More personalized medicine on the move identifying markers for cancer. BD

NEW YORK (GenomeWeb News) Three Massachusetts research hospitals will evaluate Protein Forests bioinformatics software in separate disease studies, the company said Friday. The Whitehead Institute, the Proteomics and Mass Spectrometry Facility at the University of Massachusetts Medical School, and Harvard Medical School will use the company's Mass Spec Results Analysis Tool (MSRAT) to study data generated using the company's digital ProteomeChip system.

The studies will involve seeking biomarkers for glial tumors, identifying prostate cancer markers in urine, and studying diseases linked to MHC class I and class II peptides from T cells, the Lexington, Mass.-based company said.